Nemonapride
From Infogalactic: the planetary knowledge core
![]() |
|
Systematic (IUPAC) name | |
---|---|
N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide
|
|
Clinical data | |
Trade names | Emilace (JP) |
AHFS/Drugs.com | International Drug Names |
Legal status |
|
Routes of administration |
Oral |
Identifiers | |
CAS Number | 75272-39-8 |
ATC code | none |
PubChem | CID: 4452 |
IUPHAR/BPS | 983 |
UNII | Q88T5P3444 ![]() |
KEGG | D01468 ![]() |
Chemical data | |
Formula | C21H26ClN3O2 |
Molecular mass | 387.90 g/mol |
|
|
(verify) |
Nemonapride (エミレース, Emilace (JP)) is an atypical antipsychotic approved in Japan for the treatment of schizophrenia. It was launched by Yamanouchi in 1991. Nemonapride acts as a D2 and D3 receptor antagonist, and is also a potent 5-HT1A receptor agonist. It has affinity for sigma receptors.
See also
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
Lua error in package.lua at line 80: module 'strict' not found.
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Pages with reference errors
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without InChI source
- Drugs not assigned an ATC code
- Amides
- Atypical antipsychotics
- Benzamides
- Chloroarenes
- Phenol ethers
- Pyrrolidines
- Nervous system drug stubs